(Q53485322)
Statements
Proliferative advantage rather than classical drug resistance as the cause of treatment failure in chronic myelogenous leukemia. (English)
Preisler HD
Raza A
Baccarani M
1 January 1993
11 Suppl 1
303-306
1 reference
1 reference
1 reference
1 reference
1 reference